WeSearch

Poison center reports rose 39% for a common supplement — after it was incorrectly touted as a measles cure

·7 min read · 0 reactions · 0 comments · 9 views
#health#measles#vitamins#public health#media#Robert F. Kennedy Jr.#Joe Rogan#Boston Children’s Hospital#Centers for Disease Control and Prevention#West Texas
Poison center reports rose 39% for a common supplement — after it was incorrectly touted as a measles cure
⚡ TL;DR · AI summary

Poison control centers in the U.S. reported a 39% increase in calls related to a common supplement after it was incorrectly promoted as a measles treatment. This surge in interest coincided with public statements from notable figures, including Health Secretary Robert F. Kennedy Jr. and podcaster Joe Rogan, discussing the supplement's potential benefits. Researchers found that while interest in the supplement increased significantly, they could not confirm whether this translated into actual usage.

Key facts
Original article
New York Post
Read full at New York Post →
Opening excerpt (first ~120 words) tap to expand

Health Poison center reports rose 39% for a common supplement — after it was incorrectly touted as a measles cure By McKenzie Beard Published June 6, 2026, 12:40 p.m. ET See more of our coverage in your search results. Add The New York Post on Google Just because you can grab it off a drugstore shelf doesn’t mean it’s harmless. As the US confronted a major resurgence of measles last year, poison control centers reported a sharp spike in calls involving children exposed to a widely available supplement. Around the same time, new research shows internet searches surged for whether that same vitamin could be used as an alternative treatment for the potentially deadly disease. That spike in attention came after several prominent figures — including Health Secretary Robert F. Kennedy Jr.

Excerpt limited to ~120 words for fair-use compliance. The full article is at New York Post.

Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from New York Post